Glp 1 Receptor Agonists - Pharma

Relevant Publications

Glucagon-Like Peptide 1 Agonist and Effects on Reward Behaviour: A Systematic Review.

Issue Release: 2024

Glucagon-Like Peptide-1 Receptor Agonists and Major Adverse Cardiovascular Events in Patients With and Without Diabetes: A Meta-Analysis of Randomized-Controlled Trials.

Issue Release: 2024

Efficacy and safety of glucagon-like peptide-1 receptor agonists on prediabetes: a systematic review and meta-analysis of randomized controlled trials.

Issue Release: 2024

Effect of the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide on alcohol consumption in alcohol-preferring male vervet monkeys.

Issue Release: 2024

Do anti-obesity medical treatments have a direct effect on adipose tissue?

Issue Release: 2024

Sex, racial, ethnic, and geographical disparities in major adverse cardiovascular outcome of glucagon-like peptide-1 receptor agonists among patients with and without diabetes mellitus: A meta-analysis of placebo-controlled randomized controlled trials.

Issue Release: 2024

Cutaneous hypersensitivity reaction to dulaglutide: a case report of an allergic reaction.

Issue Release: 2024

Growth differentiation factor 15 is not modified after weight loss induced by liraglutide in South Asians and Europids with type 2 diabetes mellitus.

Issue Release: 2024

CETP and SGLT2 inhibitor combination therapy increases glycemic control: a 2x2 factorial Mendelian randomization analysis.

Issue Release: 2024

Narrative review of data supporting alternate first-line therapies over metformin in type 2 diabetes.

Issue Release: 2024

Comparative Analysis of Orthosteric and Allosteric GLP-1R Agonists\' Effects on Insulin Secretion from Healthy, Diabetic, and Recovered INS-1E Pancreatic Beta Cells.

Issue Release: 2024

Unraveling the Cardiac Matrix: From Diabetes to Heart Failure, Exploring Pathways and Potential Medications.

Issue Release: 2024

Should the SELECT Trial Make Us Comfortable Using GLP-1 Receptor Agonists in HFrEF?

Issue Release: 2024

Real world study of GLP-1 receptor agonists in overweight or obese type 2 diabetes by using repeated measurement analysis of variance.

Issue Release: 2024

Reprint of: Impact of a pharmacist-led weight management service in a cardiology clinic.

Issue Release: 2024

Hemiplegic Migraines Exacerbated using an Injectable GLP-1 Agonist for Weight Loss.

Issue Release: 2024

Mortality and major adverse cardiovascular events after glucagon-like peptide-1 receptor agonist initiation in patients with immune-mediated inflammatory diseases and type 2 diabetes: A population-based study.

Issue Release: 2024

Association of glucagon-like peptide-1 receptor agonists with suicidal ideation and self-injury in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study.

Issue Release: 2024

New Molecules in Type 2 Diabetes: Advancements, Challenges and Future Directions.

Issue Release: 2024

Exogenous glucagon-like peptide 2 counteracts exogenous cholecystokinin-induced gallbladder contraction in healthy men.

Issue Release: 2024

Why is Medication Management Important?

Who Can Participate in Clinical Trials?

What is Patient Education in Pharma?

How Can ADEs be Prevented?

What is Generic Competition?

What Role Does Regulatory Affairs Play?

What Role Does Cellular Stress Play in Disease?

What are the Benefits of Collaborative Care Models?

What are the Regulatory Requirements for Generic Drugs?

What are Collaborative Care Models?

Glp 1 Receptor Agonists - Pharma

Relevant Publications

Partnered Content Networks

Relevant Topics